Pearls for Practice: Mastering the Many Faces of Osteoporosis

1:00 PM - 5:00 PM
Location: Convention Center 502 A

This session uses Audience Response System (ARS). Smart device is required for audience to participate in the Q&A via AACE 2019 app.


Rachel Pessah-Pollack, MD, FACE

Clinical Assistant Professor
Icahn School of Medicine At Mount Sinai

Rachel Pessah-Pollack, M.D., F.A.C.E. is an Assistant Clinical Professor of Medicine at the Mount Sinai School of Medicine in New York City.
She trained at the Mount Sinai School of Medicine in New York City, where she completed her Internal Medicine Residency and Endocrinology Fellowship and is Board Certified in Internal Medicine and Endocrinology, Diabetes & Metabolism. She is a member of the AACE Board of Directors and a coauthor of numerous clinical practice guidelines. She is currently a task force author on the 2019 AACE Postmenopausal Osteoporosis Guidelines and 2019 AACE Thyroid Nodule Guidelines.


Send Email for Rachel Pessah-Pollack

Pauline Camacho, MD, FACE

Professor of Medicine
Loyola University Medical Center

Dr. Pauline M. Camacho is a Professor of Medicine at Loyola University Medical Center and directs the Loyola University Osteoporosis and Metabolic Bone Disease Center. She is also the Program Director for the Endocrinology fellowship at Loyola. She obtained her medical degree from the University of the Philippines College of Medicine, and completed her Internal Medicine residency at Rush University Medical Center and endocrinology fellowship at Loyola University Medical Center. Her clinical practice and research focuses on osteoporosis and other metabolic bone diseases such as vitamin D deficiency, primary hyperparathyroidism and other calcium and mineral disorders. She has authored numerous publications, including three books in
Endocrinology. She is the lead author on the 2016 AACE Postmenopausal Osteoporosis Guidelines, and has helped author several of AACE's Guidelines. Dr. Camacho is the Immediate Past President of the American Association of Clinical Endocrinologists (AACE).


Send Email for Pauline Camacho

Daniel L. Hurley, MD

Consultant; Division of Endocrinology, Diabetes, Metabolism & NutritionAssociate Professor of Medicine, Mayo Clinic College of Medicine
Mayo Clinic, Rochester, MN


Send Email for Daniel Hurley

Michael R. McClung, MD

Founding Director
Oregon Osteoporosis Center

Dr. Michael McClung is the founding director of the Oregon Osteoporosis Center, an Adjunct Professor of Medicine at the Oregon Health & Science University and Professorial Fellow at the Mary MacKillop Institute for Health Research, Australian Catholic University in Melbourne,Australia. He graduated from Rice University in Houston and from the University of Texas Southwestern Medical School in Dallas. After his training in Internal Medicine at Parkland Hospital in Dallas, he completed a fellowship in Endocrinology at the National Institute of Health in Bethesda, Maryland. Since then, he has held several academic appointments and has been actively involved in the training of young physicians in Oregon and at sites around the world.

At the Oregon Osteoporosis Center, Dr. McClung had an active clinical practice, took part in multiple educational initiatives and was an investigator in many clinical trials evaluating the effects of therapeutic agents for osteoporosis. He serves on the Boards of the International Osteoporosis Foundation and North American Menopause Society and has been involved in the development of clinical guidelines for several national osteoporosis societies including AACE.


Send Email for Michael McClung

Felicia Cosman, MD

Professor of Medicine
Columbia University Medical Center

Dr. Felicia Cosman is a clinical scientist, osteoporosis specialist and Professor of Medicine at Columbia University. She received her undergraduate degree from Cornell and medical degree from Stony Brook, followed by an internship, residency and endocrinology fellowship at Columbia.

Dr. Cosman has had longterm NIH funding, as well as grants from the DOD, National MS Society, and industry. She has published 155 peer-reviewed papers and 50 book chapters. Early in her career, she utilized dynamic tests of the PTH/Vitamin D axis to investigate the effects of menopause, estrogen and selective estrogen receptor modulators, and to explore racial differences in skeletal metabolism. In midcareer, she studied interrelationships among MS, vitamin D deficiency and glucocorticoids, and evaluated causes of stress fractures and factors contributing to peak bone mass accrual in elite military cadets attending the USMA. She participated in studies investigating many pharmaceutical agents for osteoporosis, including longterm effects of zoledronic acid and factors associated with persistent action after discontinuation. She also studied vertebral fracture prevalence in the US.

Dr Cosman was a member of ASBMR Task Forces on Atypical Femur Fractures and Goal Directed Therapy, the NIH Pathways to Prevention workshop, Own the Bone Advisory Board (AOA), HORIZON Steering Committee and committees addressing biochemical turnover markers, vertebral fractures (NHANES), and hormone/estrogen use (NAMS). She was Clinical Director of the NOF and Chairman of the Clinician’s Guide Committee. She has been an NIH grant reviewer, associate editor for several journals, and in 2015 became Co-Editor-in-Chief of Osteoporosis International. She is a member of the AOA Medical Honor Society, received the NOF Generations Award, twice received the ASBMR Best Abstract award and was on the Castle-Connolly Top Doctor list for 18 consecutive years. She is a frequent speaker at national and international conferences.


Send Email for Felicia Cosman

Bart Clarke, MD

Professor of Medicine, Consultant
Mayo Clinic, Rochester, MN

• Bart L. Clarke, M.D. is Consultant in the Metabolic Bone Disease Core Group in the Division of Endocrinology, Diabetes, Metabolism, and Nutrition at the Mayo Clinic, and Professor of Medicine in the Mayo Clinic College of Medicine. He completed his medical training at the UCLA School of Medicine, and residency and fellowship training at the Mayo Graduate School of Medicine.
• His current clinical research interests include parathyroid disorders, including hypoparathyroidism and primary hyperparathyroidism, postmenopausal osteoporosis, glucocorticoid- and transplantation-induced osteoporosis, and tumor-induced osteomalacia.
• He is President of the American Society for Bone and Mineral Research, and a member of the American Association of Clinical Endocrinologists, Endocrine Society, and the American College of Physicians. He is a member of the Editorial Board for Bone and Osteoporosis International, served on the FDA Reproductive Health Drug Advisory Board, and is a current Chair of the Mayo Clinic Institutional Review Board.


Send Email for Bart Clarke


Pearls for Practice: Mastering the Many Faces of Osteoporosis


Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Pearls for Practice: Mastering the Many Faces of Osteoporosis